Academic
Publications
Approximately optimal designs for phase II clinical studies

Approximately optimal designs for phase II clinical studies,10.1080/10543409808835253,Journal of Biopharmaceutical Statistics,Nigel Stallard

Approximately optimal designs for phase II clinical studies   (Citations: 2)
BibTex | RIS | RefWorks Download
There is no consensus on determination of sample size in phase II clinical trials. The use of Bayesian decision theory has been proposed by Stallard (1), among others. In this article, optimal three-stage designs are obtained using decision theory. These are compared with procedures proposed by Schoenfeld (2), Ensign et al. (3), and Chen et al. (4) and the sequential probability ratio test of Wald (5) and Barnard (6). The three-stage procedures are shown to be close to the true optimal test; the sequential probability ratio test is easier to obtain and only marginally inferior.Because optimality of the decision-theory approach depends on accurate specification of costs and profits, an assessment is made of the sensitivity of the proposed procedures to a range of gain function parameter values.
Journal: Journal of Biopharmaceutical Statistics - J BIOPHARM STAT , vol. 8, no. 3, pp. 469-487, 1998
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
Sort by: